Literature DB >> 17113395

Pathophysiology of volume overload in acute heart failure syndromes.

Horng H Chen1, Robert W Schrier.   

Abstract

The inability to effectively regulate volume status is a major consequence of acute heart failure syndromes (AHFS). A variety of pathophysiologic processes contribute to this impairment, most notably neurohormonal activation of the renin-angiotensin-aldosterone system, arginine vasopressin, and the sympathetic nervous system. As a result, addressing volume overload is one of the most challenging aspects of AHFS management. Neurohormonal activation leads to substantial changes in hemodynamics and myocardial remodeling, which further contribute to the severity of heart failure (HF) disease and thereby cyclically increase the risk of further neurohormonal activation. Pulmonary capillary wedge pressure is a dependable reflection of volume status and has been used as a surrogate marker in recent studies to assess disease progression in response to innovative HF treatment strategies. Future approaches to HF treatment should focus on the more accurate assessment and management of volume status in an effort to improve patient care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113395     DOI: 10.1016/j.amjmed.2006.09.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.

Authors:  Christopher S Lee; Nancy C Tkacs; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2009 May-Jun       Impact factor: 2.083

3.  Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients.

Authors:  Adrian Valdespino-Trejo; Arturo Orea-Tejeda; Lilia Castillo-Martínez; Candace Keirns-Davis; Alvaro Montañez-Orozco; Gerson Ortíz-Suárez; D Alejandro Delgado-Pérez; Bianka Marquez-Zepeda
Journal:  Exp Clin Cardiol       Date:  2013

Review 4.  Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.

Authors:  Peter Samuel Eid; Doaa Alaa Ibrahim; Ahmad Helmy Zayan; Manal Mahmoud Abd Elrahman; Mostafa Ahmed Abdo Shehata; Hend Kandil; Mahmoud Ahmed Abouibrahim; Luc Minh Duy; Ashraf Shinkar; Muhammed Khaled Elfaituri; Le Huu Nhat Minh; Mostafa Mahmoud Fahmy; Dao Ngoc Hien Tam; Nguyen Lam Vuong; Jaffer Shah; Van Buu Dan Do; Kenji Hirayama; Nguyen Tien Huy
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

5.  Cardiorenal syndrome in acute heart failure syndromes.

Authors:  Mohammad Sarraf; Robert W Schrier
Journal:  Int J Nephrol       Date:  2011-03-02

6.  Renal dysfunction in acute heart failure.

Authors:  Seong Woo Han; Kyu Hyung Ryu
Journal:  Korean Circ J       Date:  2011-10-31       Impact factor: 3.243

Review 7.  Edema formation in congestive heart failure and the underlying mechanisms.

Authors:  Zaid Abassi; Emad E Khoury; Tony Karram; Doron Aronson
Journal:  Front Cardiovasc Med       Date:  2022-09-27

8.  Beta-adrenergic receptor antagonists and chronic heart failure in children.

Authors:  Sylvie Di Filippo
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

Review 9.  The renin-angiotensin-aldosterone system as a link between obesity and coronavirus disease 2019 severity.

Authors:  Ioannis Akoumianakis; Theodosios Filippatos
Journal:  Obes Rev       Date:  2020-06-22       Impact factor: 10.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.